Development of a new ultra‐high‐performance liquid chromatography–tandem mass spectrometry method for the determination of digoxin and digitoxin in plasma: Comparison with a clinical immunoassay
Open Access
- 17 February 2022
- journal article
- research article
- Published by Wiley in Electrophoresis
- Vol. 43 (9-10) , 1019-1026
Abstract
Cardiac glycosides digoxin and digitoxin are used in therapy for the treatment of congestive heart failure. Moreover, these compounds can be responsible for intoxication cases caused by fortuitous ingestion of leaves of Digitalis. Due to the narrow therapeutic range of these drugs, therapeutic drug monitoring is recommended in the clinical practice. In this context, immunoassays‐based methods are generally employed but digoxin‐ and digitoxin‐like compounds can interfere with the analysis. The aim of this study was to develop and validate an original UPLC–MS/MS method for the determination of digoxin and digitoxin in plasma. The method shows adequate sensitivity and selectivity with acceptable matrix effects and very good linearity, accuracy, precision, and recovery. A simple liquid–liquid extraction procedure was used for sample clean‐up. The method was applied for the analysis of n = 220 plasma samples collected in two different clinical chemistry laboratories and previously tested by the same immunoassay. The statistical comparison showed a relevant negative bias of the UPLC–MS/MS method versus the immunoassay. These results are consistent with an immunoassay overestimation of digoxin plasmatic levels due to cross‐reaction events with endogenous digoxin‐like substances.Keywords
This publication has 30 references indexed in Scilit:
- Digitoxin and its analogs as novel cancer therapeuticsExperimental Hematology & Oncology, 2012
- Simultaneous determination of various cardiac glycosides by liquid chromatography–hybrid mass spectrometry for the purity assessment of the therapeutic monitored drug digoxinJournal of Chromatography A, 2010
- Therapeutic monitoring of serum digoxin for patients with heart failure using a rapid LC-MS/MS methodClinical Biochemistry, 2010
- Validation and application of a 96-well format solid-phase extraction and liquid chromatography–tandem mass spectrometry method for the quantitation of digoxin in human plasmaJournal of Chromatography B, 2008
- Herbal Supplements and Therapeutic Drug Monitoring: Focus on Digoxin Immunoassays and Interactions With St. John's WortTherapeutic Drug Monitoring, 2008
- Sensitive and specific LC‐MS assay for quantification of digoxin in human plasma and urineBiomedical Chromatography, 2008
- Rapid Quantitation of Digoxin in Human Plasma and Urine Using Isotope Dilution Liquid Chromatography‐Tandem Mass SpectrometryJournal of Liquid Chromatography & Related Technologies, 2006
- Effect of Asian and Siberian Ginseng on Serum Digoxin Measurement by Five Digoxin ImmunoassaysAmerican Journal of Clinical Pathology, 2003
- Treatment of congestive heart failure - current status of use of digitoxinEuropean Journal of Clinical Investigation, 2001
- Treatment of congestive heart failure - current status of use of digitoxinEuropean Journal of Clinical Investigation, 2001